Your browser doesn't support javascript.
loading
Radiation-induced morphea of the breast-A case series.
Finnegan, Paula; Kiely, Lisa; Gallagher, Catriona; Mhaolcatha, Sarah Ni; Feeley, Linda; Fitzgibbon, Jim; White, Jessica; Bourke, John; Murphy, Lesley Ann.
  • Finnegan P; Department of Dermatology University Hospital Limerick Dooradoyle Limerick Ireland.
  • Kiely L; Department of Dermatology South Infirmary Victoria University Hospital Cork Ireland.
  • Gallagher C; Department of Dermatology South Infirmary Victoria University Hospital Cork Ireland.
  • Mhaolcatha SN; Department of Histopathology Cork University Hospital Wilton, Cork Ireland.
  • Feeley L; Department of Histopathology Cork University Hospital Wilton, Cork Ireland.
  • Fitzgibbon J; Department of Histopathology Cork University Hospital Wilton, Cork Ireland.
  • White J; Department of Histopathology Cork University Hospital Wilton, Cork Ireland.
  • Bourke J; Department of Dermatology South Infirmary Victoria University Hospital Cork Ireland.
  • Murphy LA; Department of Dermatology South Infirmary Victoria University Hospital Cork Ireland.
Skin Health Dis ; 3(1): e148, 2023 Feb.
Article en En | MEDLINE | ID: mdl-36751336
ABSTRACT
Radiation-induced morphea (RIM) is a rare but recognized late complication of radiotherapy. It was first described in 1905, not long after the initial discovery of X-rays by Roentgen. Characterized by the deposition of excess collagen in the dermis, it results in thickening of the skin. Its frequency is approximately 2 in 1000. We present a series of three cases involving patients receiving radiotherapy treatment for breast cancer, each of which subsequently developed RIM. Because of its rarity, RIM is often misdiagnosed as infection or metastatic disease. This can lead to delayed diagnosis and treatment, leading to poorer outcomes such as chronic pain issues. Early dermatological involvement and tissue sampling to examine histopathological features can avoid this, leading to better care and improved results. A variety of treatment options are available, ranging from topical to systemic, with early induction more likely to result in a positive response.

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2023 Tipo del documento: Article